FDA Approved Generic Drug for Attention Deficit Hyperactivity Disorder (ADHD)

Attention deficit hyperactivity disorder is a brain disorder that is usually marked with an ongoing pattern of inattention and hyperactivity that affects proper functioning and development. The United States Food and Drug Administration has recently approved the first generic version of Atomoxetine (Strattera) drug for the treatment of ADHD (Attention deficit hyperactivity disorder) in children and adults.